Compare
Dexcom vs Intuitive Surgical (DXCM vs ISRG)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Dexcom (DXCM) returned +34.0% and Intuitive Surgical (ISRG) -17.5%; so far this year the figures are +19.6% and -20.1%.
Intuitive Surgical is the larger company by market value, about 5.3 times the size of Dexcom.
On trailing earnings, DXCM trades at 31.3 times and ISRG at 54.8 times.
Revenue grew +13.0% at DXCM and +20.5% at ISRG over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| DXCM | ISRG | |
|---|---|---|
| Price | $79.41 | $452.80 |
| 1-day | -5.98% | -3.36% |
| YTD | +19.65% | -20.05% |
| 1 year | +33.96% | -17.46% |
| 3 years | -15.64% | +67.42% |
| Market cap | $29.6B | $157.0B |
| P/E | 31.3 | 54.8 |
| P/S | 5.80 | 13.56 |
| P/B | 11.68 | 9.82 |
| Revenue growth | +13.00% | +20.50% |
| EPS growth | +41.10% | +9.10% |
| Gross margin % | 63.4 | 67.2 |
| Net margin % | 19.4 | 25.5 |
| ROE % | 39.1 | 18.5 |
| Debt / equity | 0.00 | 0.00 |
| FCF yield % | 3.7 | 2.3 |
| Dividend yield % | — | — |
| Beta | 0.70 | 0.92 |
| RSI (14) | 42.8 | 57.2 |
| Technical rating |